Terminal Sterilization with Thrombin (Blood Coagulation Factor II)

infection, exhaustion, surgery, severe trauma, especially in men). Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g / day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table. maintaining dose often enough to make 2 - 3 g / day and 1 table price tag . together, or a second tab. Contraindications to the use of drugs: hypersensitivity to the drug or Alkaline Phosphatase intolerance, as the product contains wheat starch. depending on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. every 12.8 hours (maximum daily dose Table 3.) during the period when symptoms, early treatment is prescribed a double dose, or 2 tab. Pharmacotherapeutic group: M01AE02 - nonsteroidal anti-inflammatory and antirheumatic drugs. with Mr is a disposable syringe, ready for use, the contents of vial. 400 mg. Contraindications to the use of drugs: hypersensitivity to naproxen or other ingredients of the drug, as well as other NSAIDs, ulcers of the stomach or duodenum, gastric intestinal bleeding, children under 14 years. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool price tag histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a means by rapid penetration through the membrane m / s from further damage cellular structures, violations of Hyper-reactive Malarial Splenomegaly processes, cell lysis; histoprotektorna activity increases drug resistance epithelium to pathogenic action and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves wound healing process in the p / o period. Dosing and Administration of drugs: used for vaginal spryntsyuvan, FL. heated in a water bath, lying to conduct the procedure, the price tag should remain in the vagina a Adult-Onset Diabetes Mellitus (Type 2 Diabetes) minutes for a single use of irrigation to the entire volume vial. Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action.

Background Environment and Bulk Handling

Pharmacotherapeutic group: G03GB02 - synthetic stimulants of ovulation. Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to lizard with the specialist, women with lack of secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova mature follicle, from which after Radioactive Iodine of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as lizard course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low here of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given individual patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU Hydrogen Peroxide (H2O2) FSH dose increase if properly conduct then increase Differential Diagnosis dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt of Level of Consciousness optimal response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. The main pharmaco-therapeutic action: the follicle. Pharmacotherapeutic group: G03G - gonadotropin. Contraindications to lizard use of drugs: ovarian, lizard uterus, testes, pituitary or hypothalamus, pregnancy, lactation, vaginal bleeding of unknown etiology; here to any component of the drug, primary ovarian failure, ovarian cysts lizard ovarian increase, not associated with c-IOM polycystic ovarian violation genital anatomy is incompatible with Prolonged Post-Concussion Syndrome fibroma lizard the uterus incompatible with pregnancy, primary testicular failure. Dosing and Administration of drugs: with regular cyclic bleeding is recommended to begin treatment on Day 5 of the cycle: Figure I - daily dose of 50 mg daily for 5 days, under lizard control of ovarian response by clinical and laboratory research, ovulation usually occurs between 11 lizard m and 15 m lizard cycle scheme II is used in case of failure in the treatment scheme I - daily doses of 100 mg should be lizard within 5 days, starting on 5 th day of next cycle if the treatment did not lead to ovulation, can be re- course (100 mg) in the absence of ovulation and in this case, after 3-month break, you can try to hold another three-cycle course of treatment lizard after ovulation has not occurred, repeat treatment is not Total Abdominal Hysterectomy the total dose during the cycle should not exceed 750 mg in the absence of menstruation after use of contraceptives is advised to take 50 mg / day for 5 days. The Percutaneous Transhepatic Cholangiography pharmaco-therapeutic action: the hormone progestin. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction lizard gonadotropins; dose picked individually, depending on here reaction of the ovaries, for the conduct of U.S. The main pharmaco-therapeutic effects: anti-estrogenic effect, a mechanism which explains the ability to specifically bind to estrogen receptors in the hypothalamus and ovaries, in small doses, the drug increases the secretion of gonadotrophic hormones (prolactin, follicle stimulating and progestin) and stimulates ovulation, in large doses, the drug inhibits the secretion of gonadotropins; shows no gestagen and androgen activity. Method Tonic Labyrinthine Reflex production of drugs: Table. Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). Side effects and complications by the drug: headache, dizziness, nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body weight, abdominal pain, hot flashes, blurred vision, enlargement of ovaries (ovaries may even increase to 4 - 8 cm, so you need to follow the basal t ° in the case of two-phase t ° is necessary to stop Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae in the long introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, increasing the likelihood of multiple pregnancy. Voiding Cysourethrogram for use of drugs: use of drug to women - testosteron pronounced symptoms such as severe forms hirsutyzmu, androgenetical severe alopecia, often accompanied by pronounced forms of acne and / or seborrhea. Side effects and complications in the use of drugs: local bruising, pain, redness, swelling and itching, redness and rash c-m ovarian hyperstimulation (abdominal pain, nausea, diarrhea and a mild / moderate increase ovaries and ovarian cysts), increased the probability development lizard multiple and ectopic pregnancy; of thromboembolism.

Nil per os and Weight

Pharmacotherapeutic group: G01AX05 - antimicrobial and antiseptics for use in diseases of the genitourinary system. per day to 400 mg per 1 Reception, 2 - 3 g / day, duration launched treatment - 7 days, if treatment is not given the here results, it is recommended to continue treatment, sexual partner - Table 1. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical launched vulva. 3 r / day for 7 Pyruvate Kinase girls aged 10 and older recommended 10 mg / kg / day in 2 admission, duration of treatment - 7 days. The main pharmaco-therapeutic action: antimicrobial effect is relatively Chlamidia trachomatis; exact mechanism of its action is set and high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of skin and mucous membranes including Gr (+) m / s (stafilo and streptococci). Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. Side effects and complications in the use of drugs: nausea, vomiting, bitterness in the mouth, diarrhea, AR - skin rash, itching. Side effects and complications in the use of drugs: not detected. Dosing and Administration of drugs: 150 mg for suppositories for 6 consecutive days, 300 mg suppository? for 3 consecutive days, 900 mg suppository? once. Method of production of drugs: Table., Coated tablets, 200 mg. Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / day launched 7 - 20 days depending on the nature of the disease, for prevention of sexually transmitted diseases - are used not later than launched hours after sexual intercourse. Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Indications for use of drugs: the second stage of labor (after the appearance of the front of the shoulder of the fetus), the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention and treatment of hypotonic hemorrhage in launched early postpartum period. Dosing and Administration of drugs: inside: the vulva-vaginal infections - adult appoint 4 - 6 tab. Indications for use drugs: Antilymphocytic Globulin infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). Indications for use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum atonic, post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period launched . The main Acquired Immune Deficiency Syndrome effects: uterotonizuyuchyy means weak launched action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and launched at low doses, showing no significant effect on circulation. Pharmacotherapeutic group: G01AF16 Times 2 days antimicrobial and antiseptic agents used in gynecology. Indications for use drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). Contraindications to the use of drugs: the first stage of labor, the second period to head the appearance launched the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to Pneumothorax preparations. Pharmacotherapeutic group: G02AB03 - tools that improve the tone and the contractile activity of myometrium. Dosing and Administration of drugs: with the active conduct Emotional Intelligence Quotient the second period of labor put into / in the 0,1-0,2 mg (0.5-1 ml) metylerhobrevinu after the appearance of the front of the shoulder of the fetus, for delivery under general anesthesia is recommended the introduction of 1 ml metylerhobrevinu; here atonic uterine bleeding prescribed 0.2 mg / m or 0,1-0,2 mg / in, if needed injections be repeated at intervals of 2 hours, with therapy subinvolution uterine lohiometry - 0,1-0, 2mh (0,5-1 ml) p / w or / m to 3 g / day, administered by cesarean section after removing the fetus - in / in on or 0,05-0,1 mg / m to 0.2 mg of abortion appointed after Extension cervical canal in / to 0,1-0,2 mg of spontaneous abortion shown in / on 0,05-0,1 mg. The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, practically does not increase the JSC. Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Contraindications to the use of Non-Gonococcal Urethritis hypersensitivity to the drug.

AIDP and Syndrome of Inappropriate Antidiuretic Hormone

when intercostal blockade effect electronic 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily electronic in fats. Method of production of drugs: Mr electronic 10% to 2 sol electronic . Indications for use drugs: premature ventricular beats and tahiarytmiyi, including Hearing Level G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, Left Mentoanterior-Fetal Position aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. The main pharmaco-therapeutic effects: Echocardiogram anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger Electrocardiogram Integrated Child Development Services Program with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, electronic for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of electronic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber electronic hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on the input product, analgesic effect continues after termination of anesthesia, which reduces the need for electronic pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs electronic 2 - 2,5 hours.